STAT3 as a predictive biomarker in head and neck cancer: A validation study

Ruitenbeek, Niels van; Woude, Lieke L. van der; Krieken, J. Han van; Grunsven, Adriana C. H. van Engen–van; Willemsen, Annelieke E.C.A.B.; Herpen, Carla M.L. van

doi:10.1016/j.prp.2020.153172

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2023

Publication Types

Select...

Article1

Preprint1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…STAT3 has been identi ed as a prognostic biomarker in head and neck cancer and TNBC [29,30]. The study provides evidence that STAT3 is related to immunosuppression and drug response in clinical treatment [31].…”

Section: Discussionmentioning

confidence: 86%

Comprehensive Analysis of the Expression and Prognosis for STATs in Human Breast Invasive Carcinoma

Huo

Xie

2022

SSRN Journal

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 86%

Comprehensive Analysis of the Expression and Prognosis for STATs in Human Breast Invasive Carcinoma

Huo

Xie

2022

SSRN Journal

View full text Add to dashboard Cite

A comprehensive analysis of the expression and prognosis of STATs in human breast invasive carcinoma

Huo

Xie

2023

Preprint

View full text Add to dashboard Cite

Background Multiple cancer types are associated with the Signal Transducer and Activator of Transcription (STAT) family of proteins. The expression and prognostic value of STATs in breast invasive carcinoma (BRCA) remain unclear. Methods Herein we investigated the clinical data onto 1,222 patients with BRCA based on the Cancer Genome Atlas (TCGA) database, UALCAN, cBio Cancer Genomics Portal (cBioPortal), STRING, and GeneMANIA databases. Results The transcriptional levels of STAT4/5A/5B/6 were significantly decreased while the transcriptional levels of STAT1 were elevated in BRCA tissues. A significant correlation exists between STATs expressions and known prognostic factors, e.g., age, pathologic stage, radiation_therapy, and Tumor Node Metastasis (TNM) stages. It was discovered that patients with high STAT4 expression had a better prognosis for overall survival (OS) (HR = 0.59, p = 0.002), disease-specific survival (DSS) (HR = 0.59, p = 0.018), and progress free interval (PFI) (HR = 0.55, p < 0.001). STAT4 may be an independent prognostic marker for BRCA through univariate and multivariate Cox regression. In terms of immune infiltrating levels, A correlation between STAT1/2/4/13 expression and immune cell infiltration, including T cells and Th1, has also been noted. Furthermore, the levels of STAT4 were statistically significant correlated with T cells (r = 0.822, p < 0.001), cytotoxic cells (r = 0.746, p < 0.001), B cells (r = 0.691, p < 0.001), Th1 cells (r = 0.686, p < 0.001), and activated dendritic cells (DC). Conclusion Based on the findings of this study, STAT4 might serve as a novel prognostic biomarker to predict prognosis and levels of immune infiltration for BRCA.

show abstract

STAT3 as a predictive biomarker in head and neck cancer: A validation study

Cited by 2 publications

References 21 publications

Comprehensive Analysis of the Expression and Prognosis for STATs in Human Breast Invasive Carcinoma

Comprehensive Analysis of the Expression and Prognosis for STATs in Human Breast Invasive Carcinoma

A comprehensive analysis of the expression and prognosis of STATs in human breast invasive carcinoma

Contact Info

Product

Resources

About